Jagsonpal Pharmaceuticals Limited — Updates, 03-11-2025: Press Release
03-11-2025 | 07:13 pm
03-11-2025 | 07:13 pm
Jagsonpal Pharmaceuticals announced strong H1FY26 results: revenue up 10.2% to ₹150.1 Cr, PAT surged 39.2% to ₹23.4 Cr. Q2FY26 revenue was stable at ₹74.5 Cr, with PAT up 9.7% to ₹12.6 Cr, despite market price adjustments. The company maintains ₹160.4 Cr cash and appointed new COO & CFO.
No comments yet. Be the first to comment!
